ALPORT SYNDROME

Clinical trials for ALPORT SYNDROME explained in plain language.

Never miss a new study

Get alerted when new ALPORT SYNDROME trials appear

Sign up with your email to follow new studies for ALPORT SYNDROME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 5 Not yet recruiting 1 Not yet finished but already full! 1 Completed 5 Terminated 1

Promising kidney drug trial for alport syndrome halted early

Disease control Terminated

This study tested a weekly injection called lademirsen in 43 adults with Alport syndrome, a genetic condition that damages kidneys. The goal was to see if the drug could slow the loss of kidney function and check for side effects. The trial was stopped early, but the results help…

Matched conditions: ALPORT SYNDROME

Phase: PHASE2 • Sponsor: Genzyme, a Sanofi Company • Aim: Disease control

Last updated May 17, 2026 06:50 UTC

ALPORT SYNDROME

Get alerted when new ALPORT SYNDROME trials appear

Promising kidney drug trial for alport syndrome halted early